Transmit apodization of an ultrasound transducer array

Information

  • Patent Grant
  • 7695436
  • Patent Number
    7,695,436
  • Date Filed
    Friday, May 21, 2004
    20 years ago
  • Date Issued
    Tuesday, April 13, 2010
    14 years ago
Abstract
A system for temporal transmit apodization of an ultrasound transducer array. The system includes a waveform generator and an ultrasound transducer array having a plurality of transducer elements. Each of the transducer elements is driven by a signal generator that generates a periodic waveform. The duty cycle of each signal generator is determined by a predetermined setting of a duty cycle control. The duty cycle of each signal generator is calculated to achieve a desired beam profile of the transducer array, such as acoustic focusing for reducing the level of grating lobes and side lobes. Apodization is achieved by varying the effective amplitude at each array element by varying the duty cycle of the signal provided to each element.
Description
FIELD OF THE INVENTION

The present invention relates generally to ultrasound, and more particularly, to an ultrasound medical system having an ultrasound source and an acoustic transducer array.


BACKGROUND OF THE INVENTION

Sound waves that have a frequency greater than approximately 20 kHz are referred to in the art as “ultrasound.” In the medical field, ultrasound waves are useful for both diagnostic and therapeutic applications. Medical diagnostic ultrasound systems are useful for generating images of anatomical structures within a target area of a patient's body. The images are obtained by scanning a target area with waves of ultrasound energy. In therapeutic ultrasound applications, high intensity ultrasound energy is transmitted into a target area to induce changes in state of the target. High-intensity focused ultrasound (“HIFU”) pulses induce changes in tissue state through thermal effects (e.g., induced hyperthermia) and mechanical effects (e.g., induced cavitation).


The use of high intensity focused ultrasound to destroy tissue or to alter the characteristics of tissue at a target location, volume, region or area within a larger mass, body or area of anatomical tissue presents many advantages, including minimization of trauma and pain for the patient, reductions in surgical incisions, stitches and exposure of internal tissue, avoidance of damage to tissue other than that which is to be treated, altered or removed, lack of a harmful cumulative effect from the ultrasound energy on the surrounding non-target tissue, reduction in treatment costs, elimination of the need in many cases for general anesthesia, reduction of the risk of infection and other complications, avoidance of blood loss, and the ability for high intensity focused ultrasound procedures to be performed in non-hospital sites and/or on an out-patient basis.


In high-intensity focused ultrasound hyperthermia treatments, intensity of ultrasonic waves generated by a highly focused transducer increases from the source to the region of focus where it can reach a very high temperature. The absorption of the ultrasonic energy at the focus induces a sudden temperature rise of tissue, which causes ablation of a target volume of cells in the focal region. Thus, as an example, HIFU hyperthermia treatments can cause necrotization of an internal lesion without damage to the intermediate tissues. The focal region dimensions are referred to as the depth of field, and the distance from the transducer to the center point of the focal region is referred to as the depth of focus. Ultrasound is a promising non-invasive surgical technique because the ultrasonic waves provide a non-effective penetration of intervening tissues, yet with sufficiently low attenuation to deliver energy to a small focal target volume. Currently there is no other known modality that offers noninvasive, deep, localized focusing of non-ionizing radiation for therapeutic purposes. Thus, ultrasonic treatment has a great advantage over microwave and radioactive therapeutic treatment techniques.


The beam emitted by a single ultrasound focused transducer element is generally effective within a fixed region, called the “focal zone.” This focal zone frequently is smaller than the size of the target tissue. Treatment of extensive targets is consequently a problem. A solution to this shortcoming is to utilize a transducer comprising a plurality of individual transducer elements arranged closely together to form an array. These arrays are focused at the desired treatment site through a combination geometric and electronic focusing. Geometric focusing is determined by the physical geometry of the array, while electronic focusing involves the use of phase delays and wave interference to achieve constructive interference at the target tissue. Electronic focusing allows movement of the treatment location without the need for mechanical movement of the array.


When a plurality of transducer elements are arranged in an array and are energized to propagate a steerable acoustic beam, the beam includes a main lobe, a plurality of small side lobes and one or more grating lobes. Grating lobes originate from acoustic waves that combine along various axes that differ from the axis of the main lobe. Grating lobes are present in the acoustic beams propagated from nearly all linear arrays and normally contain substantial energy. Side lobes are secondary points of focus outside the treatment region as a result of diffraction of the ultrasound waves passing through a structure, such as tissue or bone. The appearance of grating lobes and side lobes decreases the power radiated to the focal point, reducing the effectiveness of treatment.


It is known in the art to minimize grating lobes and side lobes by transmit apodization, wherein the effective drive amplitude of at least a portion of the elements of an array is varied to affect the shape of the beam. Varying the transmit amplitude at individual elements of the array typically requires the use of variable or switched-rail power supplies or inefficient linear amplifiers at each drive channel. Such drive mechanisms are slow, prohibitively bulky, and costly, particularly considering the large number of array elements present in a typical transducer and the number of element apodization levels necessary for beamshaping.


Pulse width variation has previously been considered for transmit apodization in association with ultrasound imaging, such as in U.S. Pat. No. 6,135,963 to Haider and U.S. Pat. No. 6,599,245 to Ma et al. As is well-known in the art, a relatively short transmit pulse is preferable for imaging, and a single pulse is often used. If a single pulse is apodized by adjusting its width, the frequency spectrum of the electrical signal supplied to the transducer to generate a corresponding ultrasound signal will likewise be significantly modified. Thus, if various transmit apodization pulse widths are applied to different array elements, the focusing, frequency spectrum and effective amplitude of the aggregate ultrasonic treatment signal emitted by the transducer will vary. This may result in undesired effects. For example, ultrasound array elements typically have limited bandwidth so there is a severe limit to the amount of useful apodization that is possible. In addition, if the transmit waveshapes are different between elements of an array, the aggregated ultrasound signals of the elements do not efficiently form a focused beam. Also, any electrical matching required to couple the electrical signal to a transducer element can drastically alter the transmit pulse shape. As a result, apodization is of limited value for ultrasound imaging.


The desired characteristics of transmit apodization of ultrasound signals for therapeutic purposes differs considerably from signals transmitted for imaging. In particular, therapeutic transducers transmit an ultrasonic pulse train for a relatively long period of time. As a result, the center of the frequency spectrum is retained generally at the pulse repetition frequency of the pulse train and is not “pulled,” rolled-off or skewed as with a transient pulse or a pulse train of short duration. If the width of the repeating pulses is short, such as a repeating pulse train of narrow spikes, the frequency spectrum broadens out and decreases in amplitude, but the peak of the spectrum remains at the pulse repetition frequency. Likewise, as the duty cycle of the pulse train increases towards a symmetrical shape (i.e., approximately equal times in “high” and “low” logical states) the effective amplitude of an array element increases. As a result of these characteristics, transmit apodization of ultrasound signals in the manner known for imaging will not produce satisfactory results when applied to therapeutic ultrasound signals.


Still, scientists and engineers continue to seek improved ultrasound medical systems. There is a need for a more efficient way to achieve transmit apodization of therapeutic ultrasound transducers.


SUMMARY OF THE INVENTION

A system for temporal transmit apodization of an ultrasound transducer array is disclosed according to an embodiment of the present invention. The system includes a waveform generator and an ultrasound transducer array having a plurality of transducer elements.


The waveform generator includes a plurality of signal generators, each coupled to an associated duty cycle control. The signal generators each produce an electrical signal having a period, amplitude and impedance compatible with the transducer elements. The duty cycle controls are each adapted to set the duty cycle of an associated signal generator.


The ultrasound transducer array may be arranged in a pattern of concentric circles. Alternatively, a plurality of elements may be arranged linearly for subdermal insertion with a minimum of trauma to surrounding tissue.


The duty cycle of each signal generator is determined by a predetermined setting of a duty cycle control. The duty cycle of each signal generator is calculated to achieve a desired beam profile of the transducer array, such as acoustic focusing for reducing the level of grating lobes and side lobes. Apodization is achieved by varying the effective amplitude at each array element by varying the duty cycle of the signal provided to each element, rather than using variable or switched-rail power supplies, or linear amplifiers. As a result, apodization can be accomplished efficiently by digital means, using components having less complexity than commonly found with analog ultrasound systems.





BRIEF DESCRIPTION OF THE FIGURES


FIG. 1 is a block diagram of an ultrasound transmission system for therapeutic treatment according to an embodiment of the present invention;



FIG. 2 depicts a periodic pulse train generated by the system of FIG. 1;



FIG. 3 shows the representation of apodization weights versus duty cycle of the periodic pulse train of FIG. 2; and



FIG. 4 is a block diagram of an ultrasound transmission system for therapeutic treatment according to an alternate embodiment of the present invention.





DETAILED DESCRIPTION OF THE INVENTION

A system 10 for temporal transmit apodization of an ultrasound transducer array is shown in FIG. 1 according to an embodiment of the present invention. System 10 includes a waveform generator 12 and an ultrasound transducer array 14.


Transducer 14 may be any conventional type of ultrasound transducer having a plurality of transducer elements 16 that may be focused by any conventional geometric and electronic focusing means. For example, elements 16 may be arranged in a pattern of concentric circles. Alternatively, a plurality of elements 16 may be arranged linearly for subdermal insertion with a minimum of trauma to surrounding tissue.


Waveform generator 12 includes a plurality of signal generators 18, each coupled to an associated duty cycle control 20. Signal generators 18 each produce a digital, generally square-wave electrical signal having a period, amplitude and impedance compatible with elements 16 of transducer 14. Duty cycle controls 20 each are adapted to set the duty cycle of an associated signal generator 18. The drive signals produced by signal generators 18 are coupled to associated elements 16 of transducer 14 by any conventional means, such as wires 22. Although separate signal generators 18 and duty cycle controls 20 are depicted in FIG. 1, one skilled in the art will recognize that a fewer number of signal generators and/or duty cycle controls may be utilized and controlled in any conventional manner to provide electrical signals of varying duty cycles to each transducer element 16. In addition, although not shown, conventional signal conditioning may be applied to the electrical signals generated by signal generators 18 including, without limitation, filters such as bandpass filters and digital signal processors.


With continued reference to FIG. 1, a drive signal pulse train 22 is a periodic rectangular waveform. Pulse train 22 is coupled to transducer elements 16 by signal generators 18 as shown in FIG. 2. Pulse train 22 has an amplitude A, a period T0 and a pulse width τ. Pulse train 22 thus has a duty cycle of τ/T0. Elements 16 can be driven by pulse train 22, each element being driven with signals having a like amplitude “A” but different duty cycles. The frequency spectrum, G(f ), of pulse train 22 may be represented by Equation 1:










G


(
f
)


=


1

T
0







n
=

-




n
=





A





τ



sin


(

π





n






τ

T
0



)



π





n






τ

T
0










δ


(

f
-

n

T
0



)









Equation





1








where n is a term coefficient of the series of pulses in pulse train 22, δ represents the delta function and f is the frequency of the pulse train.


At the fundamental frequency of pulse train 22,







f
=


f
0

=

1

T
0




,





and n=1 such that the spectral amplitude of the pulse train is given by Equation 2:










G


(

f
0

)


=


A
π







sin


(

π






τ

T
0



)







Equation





2







By varying the duty cycle τ/T0 between 0 and 50% the effective spectral amplitude G(f 0) varies between normalized values of 0 and 1, as shown in FIG. 3. This variation may be used to weight, or apodize, the transmit amplitude of an array element 16 during therapy.


With reference to FIG. 3 in combination with FIG. 2, the period T0 may be divided into a plurality of segments “S” of equal duration. The number of segments of period T0 are preferably any value 2x, where x is zero or any positive integer. For example, if x=5, the number of segments is 32. The duty cycle of a pulse train 22 divided into 32 segments may be varied between 0/32 or 0%, and 32/32 or 100%. For the nontrivial case of 1/32 to 31/32, the spectral amplitude of pulse train 22 may vary in the form of sin(πδ) where δ now represents the duty cycle, δ=(1 to 31)/32. The apodization rises from zero at zero duty cycle to unity at 50% duty cycle, and drops off toward zero for greater duty cycles.


If an even number of segments exist, such as a period dividable into N pulse widths, then







N
2

+
1





unique levels of apodization exist. An apodization of zero equates to an off element 20, while an apodization of 1 indicates a fully-on element. A total of N/2 segments may thus be used to control an element 20 between the fully-off and fully-on states. For N=32, pulse widths ranging from 0/32 to 16/32 are possible.


Example apodization levels are tabulated of the period T0 where the number of segments “S” is 16 in Table 1.









TABLE 1







Temporal Weighting, 16 Segments









Duty




Cycle
Weight
[dB]












8/16
1.000
0.00


7/16
0.976
−0.22


6/16
0.917
−0.75


5/16
0.826
−1.66


4/16
0.706
−3.03


3/16
0.534
−5.45


2/16
0.366
−8.74


1/16
0.185
−14.68









Example apodization levels for a period T0 where the number of segments “S” is 32 is shown in Table 2:









TABLE 2







Temporal Weighting, 32 Segments









Duty




Cycle
Weight
[dB]












16/32 
1.000
0.00


15/32 
0.992
−0.07


14/32 
0.976
−0.22


13/32 
0.951
−0.44


12/32 
0.917
−.075


11/32 
0.875
−1.16


10/32 
0.826
−1.66


9/32
0.769
−2.28


8/32
0.706
−3.03


7/32
0.611
−4.28


6/32
0.534
−5.45


5/32
0.452
−6.90


4/32
0.366
−8.74


3/32
0.276
−11.17


2/32
0.185
−14.68


1/32
0.092
−20.73









With reference to FIGS. 1-3 in combination, in operation each of transducer elements 16 are driven by a signal generator 18 that generates a drive signal similar to that of FIG. 2. The duty cycle of each signal generator 18 is determined by a predetermined setting of a duty cycle control 20. The duty cycle of each signal generator 18 is preferably calculated to achieve a desired beam profile of transducer array 14, such as acoustic focusing for reducing the level of grating lobes and side lobes. Apodization is achieved by varying the effective amplitude at each array element 16 by varying the duty cycle of the signal provided to each element, rather than using variable or switched-rail power supplies, or linear amplifiers. As a result, apodization can be accomplished efficiently by digital signal generation and control means, using components having less complexity than commonly found with analog ultrasound systems. Example digital signal generation means include, without limitation, digital waveform generators, pulse width modulators and semiconductors power switching devices such as, without limitation, bipolar transistors and MOSFETs. Example digital control means include, without limitation, microprocessors, microcontrollers, computers, and predetermined instructions such as computer programs.


An alternate embodiment of the present invention, shown in FIG. 4, illustrates how the present invention may be used with a single signal generator and duty cycle control. In this implementation a system 100 for temporal transmit apodization of an ultrasound transducer array includes a transducer array 102 and a waveform generator 104.


Transducer array 102 may be any conventional type of ultrasound transducer having a plurality of transducer elements 106 that may be focused by any conventional geometric and electronic focusing means. For example, elements 106 may be arranged in a pattern of concentric circles. Alternatively, a plurality of elements 106 may be arranged linearly for subdermal insertion with a minimum of trauma to surrounding tissue.


Waveform generator 104 includes a signal generator 108 having multiple outputs 110, each output coupled to an array element 106. Signal generator 108 produces at each output 110 a digital, generally square-wave electrical signal having a period, amplitude and impedance compatible with elements 106 of transducer 102. A duty cycle control 112 is adapted to provide at least one duty cycle control signal to signal generator 108 for individually controlling the duty cycle of the signals present at outputs 110. A control 114 may utilize a processor (not shown) such as a microprocessor and a predetermined set of instructions, such as a computer program (not shown), to determine the proper duty cycle for each element 106. In one embodiment, duty cycle instructions may be provided to duty cycle control 112. Duty cycle control 112 in turn provides signal generator 108 with information regarding the required duty cycle for each output 110. Alternatively, duty cycle information for each output 110 may be stored in a conventional data memory (not shown) such as a static RAM or flash memory. The data memory may be located within duty cycle control 112 or signal generator 108.


With reference to FIGS. 2, 3 and 4 in combination, in operation each element 106 of a transducer array 104 are driven by a signal generator 108 that generates a plurality of output drive signals 110 similar to that of FIG. 2. The duty cycle of each output signal 110 is determined by a predetermined setting of a duty cycle control 112. The predetermined setting may be provided to at least one of signal generator 108 and duty cycle control 112 by a control portion 114. The duty cycle of each output 110 is preferably calculated to achieve a desired beam profile of transducer array 104, such as acoustic focusing for reducing the level of grating lobes and side lobes.


Apodization of array elements 106 is achieved by varying the effective amplitude at each element by varying the duty cycle of the signal provided to each element, rather than using variable or switched-rail power supplies, or linear amplifiers. As a result, apodization can be accomplished efficiently by digital means, using components having less complexity than commonly found with analog ultrasound systems. Example digital signal generation means include, without limitation, digital waveform generators, pulse width modulators and semiconductors power switching devices such as, without limitation, bipolar transistors and MOSFETs. Example digital control means include, without limitation, microprocessors, microcontrollers, computers, and predetermined instructions such as computer programs. In addition, a single signal generator and duty cycle control of the system 100 depicted in FIG. 4 requires fewer components as compared to the system 10 of FIG. 1.


System 100 provides several features, such as programmability of elements 106 duty cycles for varying conditions and needs. For example, the duty cycle may be varied in response to a feedback signal (not shown) indicating a need for a change in the electronic focus of transducer array 102 or the effective amplitude of the ultrasound signal emitted by the transducer array. Control 114 may respond to the change requirement by adjusting the duty cycle of each transducer element 106 in a predetermined manner to accomplish the change.


While the present invention has been illustrated by a description of several embodiments, it is not the intention of the applicants to restrict or limit the spirit and scope of the appended claims to such detail. Numerous other variations, changes, and substitutions will occur to those skilled in the art without departing from the scope of the invention. For instance, the ultrasound medical system of the invention has application in ultrasound imaging and robotic assisted surgery taking into account the obvious modifications of such systems, components and methods to be compatible with such a imaging and robotic systems. It will be understood that the foregoing description is provided by way of example, and that other modifications may occur to those skilled in the art without departing from the scope and spirit of the appended claims.

Claims
  • 1. A system for generating a therapeutic ultrasound signal, comprising: a medical-treatment transducer array having a plurality of transducer elements, each element being adapted to convert a periodic electrical signal to an ultrasound signal; anda waveform generator coupled to at least one transducer element and including: at least one signal generator adapted to transmit a periodic electrical signal to the transducer element, andat least one duty cycle control adapted to control the duty cycle of the periodic electrical signal of an associated signal generator,wherein the duty cycle of the periodic electrical signal is associated with a plurality of weighted apodization levels derived by dividing the period of the periodic electrical signal into a plurality of equal segments, andwherein each of at least a plurality of the transducer elements emit ultrasound signals having a different effective amplitude from each other of the plurality of the transducer elements in accordance with the duty cycle of an associated periodic electrical signal, such that the transducer array emits an apodized therapeutic ultrasound signal.
  • 2. The system of claim 1 wherein: each transducer element is separately coupled to one of a plurality of signal generators;each signal generator is coupled to one of a plurality of duty cycle controls; andeach duty cycle control is adapted control the duty cycle of an associated signal generator such that each signal generator generates a predetermined periodic electrical signal.
  • 3. The system of claim 1 wherein the periodic electrical signal to the transducer element is a rectangular waveform.
  • 4. The system of claim 1 wherein the apodized ultrasound signal is tailored to reduce the level of grating lobes and side lobes.
  • 5. A method for generating a therapeutic ultrasound signal, comprising the steps of: providing a medical-treatment transducer array having a plurality of transducer elements, each element being adapted to convert a periodic electrical signal to an ultrasound signal;coupling to at least one transducer element a waveform generator having: at least one signal generator adapted to generate and transmit a periodic electrical signal to the transducer element, andat least one duty cycle control adapted to control the duty cycle of the periodic electrical signal of an associated signal generator; andassociating the duty cycle of the periodic electrical signal with a plurality of weighted apodization levels derived by dividing the period of the periodic electrical signal into a plurality of equal segments,wherein each of at least a portion of the transducer elements emit ultrasound signals having a different effective amplitude from each other of the portion of the transducer elements in accordance with the duty cycle of an associated periodic electrical signal, such that the transducer array emits an apodized therapeutic ultrasound signal.
  • 6. The method of claim 5, further comprising the steps of: separately coupling one of a plurality of signal generators to each transducer element;separately coupling one of a plurality of duty cycle controls to each signal generator; andwherein each duty cycle control is adapted control the duty cycle of an associated signal generator such that each signal generator generates a predetermined periodic electrical signal.
  • 7. The method of claim 5, further comprising the step of providing a rectangular periodic electrical signal to the transducer element.
  • 8. The method of claim 5, further comprising the step of tailoring the apodized ultrasound signal to reduce the level of grating lobes and side lobes.
  • 9. A system for generating a therapeutic ultrasound signal, comprising: a medical-treatment transducer array having a plurality of transducer elements, each element being adapted to convert a periodic electrical signal to an ultrasound signal; anda waveform generator coupled to at least one transducer element, including: a signal generator adapted to generate and transmit a plurality of periodic electrical signals to the transducer elements by means of a plurality of outputs,a duty cycle control adapted to control the duty cycle of the periodic electrical signals generated by the signal generator, anda control portion adapted to control at least one of the duty cycle control and the signal generator;wherein the duty cycle of the periodic electrical signal is associated with a plurality of weighted apodization levels derived by dividing the period of the periodic electrical signal into a plurality of equal segments, andwherein each of at least a portion of the transducer elements emit ultrasound signals having a different effective amplitude from each other of the portion of the transducer elements in accordance with the duty cycle of an associated periodic electrical signal, such that the transducer array emits an apodized therapeutic ultrasound signal.
  • 10. The system of claim 9 wherein the control portion is a digital control.
  • 11. The system of claim 9 wherein the periodic electrical signal to the transducer elements is a rectangular waveform.
  • 12. The system of claim 9 wherein the apodized ultrasound signal is tailored to reduce the level of grating lobes and side lobes.
  • 13. A method for generating a therapeutic ultrasound signal, comprising the steps of: providing a medical-treatment transducer array having a plurality of transducer elements, each element being adapted to convert a periodic electrical signal to an ultrasound signal; andcoupling to at least one transducer element a waveform generator having: a signal generator adapted to generate and transmit a periodic electrical signal to the transducer element,a duty cycle control adapted to control the duty cycle of the periodic electrical signal of an associated signal generator, anda control portion adapted to control at least one of the duty cycle control and the signal generator; andassociating the duty cycle of the periodic electrical signal with a plurality of weighted apodization levels derived by dividing the period of the periodic electrical signal into a plurality of equal segments,wherein each of at least a portion of the transducer elements emit ultrasound signals having a different effective amplitude from each other of the portion of the transducer elements in accordance with the duty cycle of an associated periodic electrical signal, such that the transducer array emits an apodized therapeutic ultrasound signal.
  • 14. The method of claim 13, further comprising the step of providing a digital control.
  • 15. The method of claim 13, further comprising the step of providing a rectangular periodic electrical signal to the transducer element.
  • 16. The method of claim 13, further comprising the step of tailoring the apodized ultrasound signal to reduce the level of grating lobes and side lobes.
US Referenced Citations (151)
Number Name Date Kind
3168659 Bayre et al. Feb 1965 A
3902501 Citron et al. Sep 1975 A
3927557 Viertl Dec 1975 A
4748985 Nagasaki Jun 1988 A
4757820 Itoh Jul 1988 A
4798215 Turner Jan 1989 A
4844080 Frass et al. Jul 1989 A
4858613 Fry et al. Aug 1989 A
4937767 Reuschel et al. Jun 1990 A
4960109 Lele Oct 1990 A
5117832 Sanghvi et al. Jun 1992 A
5238007 Giele et al. Aug 1993 A
5242437 Everett et al. Sep 1993 A
5295484 Marcus et al. Mar 1994 A
5305731 Buchholtz Apr 1994 A
5348017 Thornton et al. Sep 1994 A
5391197 Burdette et al. Feb 1995 A
5413550 Castel May 1995 A
5419335 Hartmann et al. May 1995 A
5458597 Edwards et al. Oct 1995 A
5465724 Sliwa et al. Nov 1995 A
5471988 Fujio et al. Dec 1995 A
5485839 Aida et al. Jan 1996 A
5492126 Hennige et al. Feb 1996 A
5500012 Brucker et al. Mar 1996 A
5501655 Rolt et al. Mar 1996 A
5514085 Yoon May 1996 A
5547459 Kaufman et al. Aug 1996 A
5549638 Burdette Aug 1996 A
5558092 Unger et al. Sep 1996 A
5571088 Lennox et al. Nov 1996 A
5575288 Sliwa et al. Nov 1996 A
5588432 Crowley Dec 1996 A
5620479 Diederich Apr 1997 A
5630837 Crowley May 1997 A
5657760 Ying et al. Aug 1997 A
5694936 Fujimoto et al. Dec 1997 A
5715825 Crowley Feb 1998 A
5728062 Brisken Mar 1998 A
5733315 Burdette et al. Mar 1998 A
5735280 Sherman et al. Apr 1998 A
5759154 Hoyns Jun 1998 A
5762066 Law et al. Jun 1998 A
5771896 Sliwa et al. Jun 1998 A
5800379 Edwards Sep 1998 A
5820580 Edwards et al. Oct 1998 A
5842994 TenHoff et al. Dec 1998 A
5860974 Abele Jan 1999 A
5876399 Chia et al. Mar 1999 A
5897523 Wright et al. Apr 1999 A
5931848 Saadat Aug 1999 A
5979453 Savage et al. Nov 1999 A
5997534 Tu et al. Dec 1999 A
6001069 Tachibana et al. Dec 1999 A
6004269 Crowley et al. Dec 1999 A
6007499 Martin et al. Dec 1999 A
6014897 Mo Jan 2000 A
6022319 Willard et al. Feb 2000 A
6027449 Mezess et al. Feb 2000 A
6106469 Suzuki et al. Aug 2000 A
6112123 Kelleher et al. Aug 2000 A
6135963 Haider Oct 2000 A
6135971 Hutchinson et al. Oct 2000 A
6138513 Barabash et al. Oct 2000 A
6148224 Jensen Nov 2000 A
6171248 Hossack et al. Jan 2001 B1
6176842 Tachibana et al. Jan 2001 B1
6183469 Thapilyal et al. Feb 2001 B1
6216704 Ingle et al. Apr 2001 B1
6217576 Tu et al. Apr 2001 B1
6221018 Ramamurthy et al. Apr 2001 B1
6231834 Unger et al. May 2001 B1
6361531 Hissong Mar 2002 B1
6379320 Lafon et al. Apr 2002 B1
6425867 Vaezy et al. Jul 2002 B1
6482178 Andrews et al. Nov 2002 B1
6508774 Acker et al. Jan 2003 B1
6512957 Witte Jan 2003 B1
6521211 Unger et al. Feb 2003 B1
6533726 Lizzi et al. Mar 2003 B1
6546934 Ingle et al. Apr 2003 B1
6575956 Brisken et al. Jun 2003 B1
6599245 Ma et al. Jul 2003 B1
6602251 Burbank et al. Aug 2003 B2
6613004 Vitek et al. Sep 2003 B1
6618620 Freundlich et al. Sep 2003 B1
6626855 Weng et al. Sep 2003 B1
6645202 Pless et al. Nov 2003 B1
6669638 Miller et al. Dec 2003 B1
6716184 Vaezy et al. Apr 2004 B2
6719449 Laugharn et al. Apr 2004 B1
6719694 Weng et al. Apr 2004 B2
6764488 Burbank et al. Jul 2004 B1
6770070 Balbierz Aug 2004 B1
6783524 Anderson et al. Aug 2004 B2
6887239 Elstrom et al. May 2005 B2
6902536 Manna et al. Jun 2005 B2
6921371 Wilson Jul 2005 B2
6936024 Houser Aug 2005 B1
6936048 Hurst Aug 2005 B2
6974417 Lockwood et al. Dec 2005 B2
7037306 Podany et al. May 2006 B2
7063666 Weng et al. Jun 2006 B2
7078015 Unger Jul 2006 B2
20010007940 Tu et al. Jul 2001 A1
20010014805 Burbank et al. Aug 2001 A1
20010037073 White et al. Nov 2001 A1
20020065512 Fjeld et al. May 2002 A1
20020068934 Edwards et al. Jun 2002 A1
20020087081 Serrano et al. Jul 2002 A1
20020087083 Nix et al. Jul 2002 A1
20020111662 Iaizzo et al. Aug 2002 A1
20020165579 Burbank et al. Nov 2002 A1
20020183742 Carmel et al. Dec 2002 A1
20020183771 Burbank et al. Dec 2002 A1
20020193781 Loeb Dec 2002 A1
20030004434 Greco et al. Jan 2003 A1
20030013960 Makin et al. Jan 2003 A1
20030013971 Makin et al. Jan 2003 A1
20030018266 Makin et al. Jan 2003 A1
20030018358 Saadat Jan 2003 A1
20030028111 Vaezy et al. Feb 2003 A1
20030040698 Makin et al. Feb 2003 A1
20030047582 Sonnenschein et al. Mar 2003 A1
20030073907 Taylor Apr 2003 A1
20030109786 Irioka et al. Jun 2003 A1
20030120270 Acker Jun 2003 A1
20030144593 Whitmore et al. Jul 2003 A1
20030212331 Fenton et al. Nov 2003 A1
20030212332 Fenton et al. Nov 2003 A1
20030220568 Hansmann et al. Nov 2003 A1
20040006336 Swanson Jan 2004 A1
20040030268 Weng et al. Feb 2004 A1
20040143252 Hurst Jul 2004 A1
20040236375 Redding, Jr. Nov 2004 A1
20040254570 Hadjicostis et al. Dec 2004 A1
20050015107 O'Brien Jan 2005 A1
20050085726 Lacoste et al. Apr 2005 A1
20050137520 Rule et al. Jun 2005 A1
20050228286 Messerly et al. Oct 2005 A1
20050240125 Makin et al. Oct 2005 A1
20050261585 Makin et al. Nov 2005 A1
20050261587 Makin et al. Nov 2005 A1
20050261588 Makin et al. Nov 2005 A1
20050267488 Hare et al. Dec 2005 A1
20060052695 Adam Mar 2006 A1
20060052701 Carter et al. Mar 2006 A1
20060173348 Wilser et al. Aug 2006 A1
20060235306 Cotter et al. Oct 2006 A1
20070021691 Nita et al. Jan 2007 A1
20080058648 Novak et al. Mar 2008 A1
Related Publications (1)
Number Date Country
20050261610 A1 Nov 2005 US